Medline Recalls Medical Kits Due to Seal Integrity Issues
Medline Industries, LP recalled 7,570 medical convenience kits on December 24, 2025. The kits contain BD ChloraPrep Triple Swabsticks with an open seal risk. Healthcare providers and patients should stop using these kits immediately.
Quick Facts at a Glance
Recall Date
December 24, 2025
Hazard Level
HIGH
Brand
Medline Industries, LP
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
Medline Industries, LP is issuing a recall for specific items and lots of Medline Kits containing BD ChloraPrep Triple Swabsticks which BD determined may exhibit an open seal on the packaging of the applicators.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medline Industries, LP or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
Medline medical convenience kits are designed for various medical procedures, providing healthcare professionals with necessary tools and sterile supplies. These kits are commonly used in hospitals and clinics for procedures involving central lines or ports.
Why This Is Dangerous
The potential open seal on the BD ChloraPrep Triple Swabsticks can compromise their sterility, which increases the risk of infection during medical procedures. Sterility is critical for any medical device that comes into contact with open wounds or invasive procedures.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
The recall affects a significant number of medical kits, posing a potential health risk to patients if used. Healthcare providers must ensure they do not use recalled kits to maintain patient safety.
Practical Guidance
How to identify if yours is affected
Locate the SKU on your Medline kit packaging.
Compare the SKU with the recalled list: DT22710, DYNDA1857A, DYNDC1978A, etc.
Check any lot numbers mentioned in the recall notice.
Where to find product info
SKU and lot numbers can typically be found on the packaging or label of the kit, often near the barcode or product description.
What timeline to expect
Expect a refund or replacement process to take approximately 4-6 weeks.
If the manufacturer is unresponsive
Document all correspondence with Medline Industries.
Try reaching out again via different methods (phone, email).
Consider filing a complaint with the FDA if the response is unsatisfactory.
How to prevent similar issues
Always check for product recalls before purchasing medical supplies.
Verify the integrity of packaging before use.
Purchase medical products from reputable sources.
Documentation advice
Keep records of your purchase, including receipts and correspondence regarding the recall for your records.
Product Details
Affected products include: Cancer Service Port Kit (SKU DT22710), Line Kit (SKU DYNDA1857A), PICC Removal Kit (SKU DYNDC1978A), and others. Sold nationwide in the U.S. since their distribution.
Key Facts
Recall date: December 24, 2025
High hazard level due to potential infection risk
Total quantity recalled: 7,570 kits
Affected kit SKUs include DT22710, DYNDA1857A, and others
Medline Industries, LP recalled 60 medical convenience kits worldwide due to a potential rotating adaptor unwinding in NAMIC Angiographic RA control syringes. The issue may cause a loose connection or disconnection between the syringe and manifold. Healthcare providers should stop using the device and follow the manufacturer’s recall instructions.
Medline Industries, LP recalled 439 medical convenience kits containing NAMIC Angiographic Rotating Adaptor syringes. The recall spans worldwide distribution including the US, Puerto Rico, and multiple international markets.
Medline Industries, LP recalls 762 medical convenience kits containing NAMIC Angiographic Rotating Adaptor syringes sold worldwide, including the U.S., PR, Canada, and several international markets. The recall cites a potential risk that the syringe rotating adaptor may unwind during use, creating a loose connection or disconnect between the syringe and the manifold. Stop using the device and seek
Medline Industries, LP recalls 17,902 medical convenience kits worldwide after post-market surveillance found a potential risk of the syringe rotating adaptor unwinding. The recall covers NAMIC Angiographic RA control syringes labeled in 10 Medline SKUs. Healthcare providers should stop use immediately and follow recall instructions.
Medline Industries issued a Class I recall for 79,843 medical convenience kits containing NAMIC Angiographic Rotating Adaptor syringes. The action covers worldwide distribution including the US and PR. The risk is a syringe adaptor unwinding during use, which may cause a loose connection or disconnection with the manifold. Stop using the device immediately and follow recall instructions.
Medline Industries recalls 192,690 Angiographic Control Syringes worldwide after post-market surveillance found a rotating adaptor may unwind. The defect can cause a loose or complete disconnection between syringe and manifold. Stop using immediately and follow recall instructions.
Medline Industries, LP recalls 3,120 medical convenience kits worldwide due to a risk the syringe rotating adaptor may unwind during use. The issue can create a loose connection or complete disconnection between the syringe and manifold. The recall was issued on February 27, 2026 and is active. Customers should stop using the kit and follow manufacturer instructions for recall notices.
Medline Industries, LP recalls 1,698 medical convenience kits worldwide over a potential unwind of the NAMIC Angiographic Rotating Adaptor during use. The risk could cause a loose connection or complete disconnection between the syringe and manifold. Healthcare providers and patients should stop using the affected kits immediately and follow recall instructions.